Trump drops 20% Hormuz cargo fee plan, bets on Gulf investment deals instead

India, July 14 -- US President Donald Trump on Tuesday scrapped his proposal to impose a 20 per cent reimbursement fee on all cargo passing through the Strait of Hormuz, saying it would instead be rep... Read More

Casino Trends: Regulations and what players should know

Nigeria, July 14 -- What Slotozilla Can Tell Us About Online Casino Trends and What Players Can Expect in 2026 Places like Slotozilla represent a very particular crossroads in the iGaming universe. T... Read More

Assam: Five friends detained over college student's death in Lakhimpur

North Lakhimpur, July 14 -- Police on Monday detained five friends of a college student who died under unclear circumstances during a picnic at the Sesa River, near the Assam-Arunachal Pradesh border,... Read More

Dylan Sprouse And Barbara Palvin Reveal Their Baby's Gender. And Yes, They've Already Picked A Sweet Nickname

India, July 14 -- Dylan Sprouse and Barbara Palvin have shared another sweet milestone from their journey to parenthood. Just weeks after announcing that they are expecting their first child together,... Read More

ASEAN Set to Honour Mining Excellence at 5th ASEAN Mineral Awards in Kuala Lumpur

Jakarta, July 14 -- JAKARTA, 14 July 2026- The spotlight will soon shine on the region's mining sector as ASEAN prepares to honour top-performing companies in the 5 th ASEAN Mineral Awards (AMA). T... Read More

US-Israel-Iran War Latest News: Trump Says Iran 'Shot First' Amid Qeshm Island Comes Under Attack as Oil Prices Surge

India, July 14 -- US-Israel-Iran War Latest News: In the current standoff between the US, Israel and Iran, there is new tension being caused by President Trump of the United States, who says that Iran... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, July 14 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More

Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, July 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, July 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... Read More

Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, July 14 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... Read More

• ««
• «
• 172
• 173
• 174
• 175
• 176
• 177
• 178
• 179
• 180
• 181
• »
• »»